Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Busy address KBO
53 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Amador Bioscience from Hasselt, company number BE0779966013, closed financial year 2025 with a result of € 267,760 after tax. For that financial year Amador Bioscience recorded a gross margin of € 2.3 million and equity of € -2.3 million. Compared with financial year 2024, the result moved from € -899,719 to € 267,760. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 21, 2026.
€ -2.3 million
▲ € 267,760 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 267,760
▲ still € 899,719 loss in 2024
Profit after tax over the fiscal year.
€ 572,106
▲ € 435,459 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -2.4 million.
People and assets in 2025
€ 468,680
▼ 21% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,292
▼ 94% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.8 million
Loans from banks and other lenders, long and short.
€ 634,618
▲ € 566,173 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 87,516
▼ 60% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -162,734 | € -355,449 | € -201,554 | € 2,282,265 | ▲ € 2.5 million |
| Profit after taxes | € -632,406 | € -1,164,701 | € -899,719 | € 267,760 | ▲ € 1.2 million |
| Equity | € -532,406 | € -1,697,106 | € -2,596,825 | € -2,329,065 | ▲ € 267,760 |
| Total debts | € 800,254 | € 1,956,898 | € 3,053,095 | € 3,545,479 | ▲ 16% |
| Cash | € 100,737 | € 4,983 | € 136,648 | € 572,106 | ▲ € 435,459 |
| Retained profit | € -632,406 | € -1,797,106 | € -2,696,825 | € -2,429,065 | ▲ € 267,760 |
| Bank debt | € 0 | € 0 | € 0 | € 2,807,860 | |
| Balance sheet total | € 267,849 | € 259,791 | € 456,270 | € 1,216,414 | ▲ 167% |
| Employees (FTE) | 4.7 | 8.6 | - | - |
Key figures of Amador Bioscience, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Amador Bioscience?
What happened at Amador Bioscience in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 267,760. Source: NBB ↗
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 632,406 loss in 2022 to € 267,760 profit in 2025.
Paid € 1,137 in corporate taxes since 2022.
Best year ever: 2025, with € 267,760 profit.
A new publication or filing at Amador Bioscience? We notify you, reason included.
Follow Amador BioscienceDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Hendrik van Veldekesingel 150 box 61
3500 Hasselt
Kempische steenweg 309 box 1.03
3500 Hasselt
Active since 11 January 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.
All companies at this address →PUTZEYS
€ 83,987 gross margin · 2025
TRUCA
€ 47,248 gross margin · 2025
Exipnos
€ -29,360 gross margin · 2022
Nationale Belgische Taekwon-do Unie
ALLANTA
€ 1.8 million revenue · 2025
+48 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0779.966.013
- VAT number
- BE 0779.966.013
- Registered office
- Hendrik van Veldekesingel 150 bus 61, 3500 Hasselt
- Names & denominations
- Amador Bioscience
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2022
- Peppol
- Active · Active since 7 May 2026
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige diensten op het gebied van informatietechnologie en computer
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied